The Genomic Research Center, opened at the Russian Scientific Center for Surgery (RSCS), will develop algorithms for the personalized use of 11 groups of essential drugs and over 20 pharmacogenetic test systems by 2030. This was reported by TASS, citing the center’s director, Konstantin Kotenko.
“Pharmacogenetics is ceasing to be just an area of scientific interest, becoming a practical tool for physicians to organize therapy, predict effectiveness, and minimize risks. And it is here that the world-class genomic research center, the ‘Center for Predictive Genetics, Pharmacogenetics, and Personalized Therapy,’ established at the RNCH, comes to the forefront,” Kotenko stated at a meeting of the Council for Personalized Medicine under the Presidium of the Russian Academy of Sciences.
Pharmacogenetics is the science of human genetic characteristics that affect drug tolerance. Specialists in this relatively new discipline are particularly involved in personalized pharmacotherapy—selecting medications and their dosages for a specific patient.
“We are focusing on conducting genome-wide studies of Russian patients, developing pharmacogenetic algorithms and diagnostic panels adapted specifically for the Russian Federation. By 2030, the center plans to have therapy personalization algorithms for 11 groups of vital drugs and to create more than 20 domestic pharmacogenetic test systems,” the scientist explained.
At the end of last year, Russia approved a healthcare development strategy, which includes, among other things, the implementation of genetic technologies and the development of personalized medicine.
